|
Plenty of options after breast cancer surgery
Congratulations on being a breast cancer survivor! Breast cancer affects one in approximately eight women in America and because of improved surveillance and treatment there are more than 2.5 million breast cancer survivors in the United States. I can not overemphasize the importance of talking to your doctor about self-examinations and mammograms for routine surveillance, which leads to early ...
www.miamiherald.com
Celldex’s CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated ...
Celldex Therapeutics, Inc. today announced preliminary results from the Company’s randomized Phase 2b EMERGE study of CDX-011 antibody drug conjugate in patients with glycoprotein NMB expressing, advanced, heavily pretreated breast cancer.
finance.yahoo.com
The Canadian Breast Cancer Foundation Invites Ontarians to "Get On Board for Breast Health"
"The Pink Tour" hits the road for summer-long education program LONDON , ON, May 23, 2012 /CNW/ - Communities across the province will be seeing pink this summer as the Canadian Breast Cancer ...
ca.finance.yahoo.com
Celldex Targeted Drug Shrinks Breast Cancer
if !IE--endif--Content on this page requires a newer version of Adobe Flash Player.if !IE--endif-- NEEDHAM, Mass. (TheStreet) --Celldex Therapeutics announced results Wednesday from a mid-stage study of its targeted cancer drug CDX-011 demonstrating superior response rates in patients with advanced metastatic breast cancer compared to single-agent chemotherapy. As hoped, CDX-011 worked best in a ...
www.thestreet.com
MRI may predict chemotherapy effectiveness early in breast cancer patients
Magnetic resonance imaging (MRI) scans may provide an early measure of how women will respond to chemotherapy for breast cancer
www.foxnews.com
Fearing breast cancer's costs
Maribel Palacios, manager of patient and family services at the American Cancer Society in White Plains, standing, assists Rica Mendes of South Salem, 37, with finding a wig last month at the ACS offices at 2 Lyon Place.
www.lohud.com
Cancer doctors put competition aside to share treatment options for their patients
Over an informal dinner in a Chevy Chase home, 25 doctors peppered one another with questions about prostate cancer treatments and clinical trials. By the end of the meal they had received a real-time, one-stop update. Several promised to refer their patients for trials. Read full article >>
www.washingtonpost.com
Frost & Sullivan: New Innovations in the Rapidly Growing U.S. Breast Cancer Pharmaceutical Market
MOUNTAIN VIEW, Calif., May 16, 2012 /PRNewswire/ -- Although there are approximately 27 drugs on the market indicated for the treatment of breast cancer, there is currently an unmet need to treat patients. ...
finance.yahoo.com
Panobinostat able to target and destroy triple negative breast cancer
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
www.news-medical.net
Blocking DNA: HDAC inhibitor targets triple negative breast cancer
( BioMed Central ) The histone de-acetylase inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open-access journal Breast Cancer Research. Researchers from Tulane University Health Sciences Center have shown that panobinostat was able to destroy breast cancer cells and reduce tumor growth in mice.
www.eurekalert.org
|
